ESC 365 - SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?

ESC Premium Access

SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?

Session: Everything you need to know about SGLT2 inhibitors in heart failure

Topic: Chronic Heart Failure

Speaker: Doctor K. Damman (Groningen, NL)

Event: ESC Congress 2021 - The Digital Experience

Presentation

About the speaker

Doctor Kevin Damman

University Medical Center Groningen, Groningen (Netherlands (The))

10 presentations

1 follower

3 more presentations in this session

Who should be treated with an SGLT2 inhibitor?

Speaker: Professor J. McMurray (Glasgow, GB)

SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

Speaker: Professor A. Cahn (Jerusalem, IL)

Everything you need to know about SGLT2 inhibitors in heart failure – discussion.

Access the full session

Everything you need to know about SGLT2 inhibitors in heart failure

Speakers: Doctor K. Damman, Professor J. McMurray, Professor A. Cahn

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ACVC Premium Access

Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention

18 March 2022

ACVC Premium Access

Clinical utility of the SCAI classification in cardiogenic shock patients of any etiology treated by a multidisciplinary team.

18 March 2022

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by